Dexmedetomidine Added to Propofol for Drug Induced Sleep Endoscopy

E

Essam Fathi

Status and phase

Completed
Phase 4

Conditions

Obstructive Sleep Apnea of Adult

Treatments

Drug: Dexmedetomidine
Drug: Propofol

Study type

Interventional

Funder types

Other

Identifiers

NCT03091894
3-2017-021

Details and patient eligibility

About

This study evaluate the effect of adding dexmedetomidine intravenous infusion to propofol intravenous infusion during sedation for drug induced sleep endoscopy. Twenty five patients will receive propofol only while the other twenty five will receive propofol and dexmedetomidine.

Full description

Propofol is a commonly used intravenous anesthetic drug used for procedural sedation. Dexmedetomidine is an alpha 2 adrenergic receptor agonist which has a sedative and analgesic effects.In the current study the success of the sedation during drug induced sleep endoscopy will be assessed.

Enrollment

50 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age more than 18 years
  • patients with obstructive sleep apnea
  • ASA 1and2

Exclusion criteria

  • patient refusal
  • age less than 18 years
  • morbid obesity
  • known or suspected allergy to the studied drugs

Trial design

50 participants in 2 patient groups

propofol
Active Comparator group
Description:
patients will receive only propofol intravenous infusion for sedation
Treatment:
Drug: Propofol
propofol-dex.
Active Comparator group
Description:
patients will receive dexmedetomidine in addition to propofol intravenous infusion for sedation
Treatment:
Drug: Propofol
Drug: Dexmedetomidine

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems